Michael W. Dunne - Jul 1, 2023 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Michael W. Dunne
Stock symbol
ITRM
Transactions as of
Jul 1, 2023
Transactions value $
$0
Form type
4
Date filed
7/3/2023, 08:00 AM
Previous filing
Jun 15, 2023
Next filing
Oct 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Options Exercise +1.78K +3.33% 55.3K Jul 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Restricted Share Units Options Exercise $0 -1.78K -100% $0.00* 0 Jul 1, 2023 Ordinary Shares 1.78K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2 On September 25, 2022, the reporting person was granted an award of 1,799 RSUs, which vested in full on July 1, 2023.